Skip to Main Content

Paper Details

Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.
Mol Cancer Res
4
2023

Datasets

Release 1.2